Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Emily Hibbitts · SciRah

Researcher profile · Semantic Scholar

Emily Hibbitts

Share profile

Emily Hibbitts — researcher profile on SciRah

h-index: 10
Works: 29
Citations: 572

Most-cited papers

Prospective Analysis of a Risk-Based Treatment Strategy for Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Patients Under 30 Years of Age: A Report from Children’s Oncology Group Study ARST0332
S. Spunt, L. Million, Yueh-Yun Chi, James R. Anderson +17 more
2019The Lancet Oncology143 citations Open access
Semantic Scholar
Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group
Emily Hibbitts, Yueh-Yun Chi, D. Hawkins, F. Barr +9 more
2019Cancer Medicine138 citations Open access
Semantic Scholar
Predictors of Differential Response to Induction Therapy in High-Risk Neuroblastoma: A Report from the Children’s Oncology Group (COG)
N. Pinto, A. Naranjo, Emily Hibbitts, S. Kreissman +7 more
2019European Journal of Cancer84 citations Open access
Semantic Scholar
The Ganglioside, GD2, as a Circulating Tumor Biomarker for Neuroblastoma
F. Balis, Christine M. Busch, A. Desai, Emily Hibbitts +4 more
2019Pediatric Blood & Cancer59 citations Open access
Semantic Scholar
Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.
Elizabeth A. Mullen, Yueh-Yun Chi, Emily Hibbitts, James R. Anderson +8 more
2018Journal of Clinical Oncology35 citations Open access
Semantic Scholar
Association of heterogeneous MYCN amplification with clinical features, biological characteristics, and outcomes in neuroblastoma: A report from the Children’s Oncology Group
Kevin M. Campbell, A. Naranjo, Emily Hibbitts, J. Gastier-Foster +6 more
2020European Journal of Cancer28 citations Open access
Semantic Scholar
The impact of propofol exposure on neurocognitive outcomes in children with high-risk B acute lymphoblastic leukemia: A Children’s Oncology Group study
S. Alexander, J. Kairalla, S. Gupta, Emily Hibbitts +13 more
2024Journal of Clinical Oncology20 citations Open access
Semantic Scholar
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children’s Oncology Group trial AALL15P1
Erin M. Guest, J. Kairalla, M. Devidas, Emily Hibbitts +17 more
2024Haematologica15 citations Open access
Semantic Scholar
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children’s Oncology Group (COG) Report
N. Pinto, A. Naranjo, Xiang-Ming Ding, Fan F. Zhang +12 more
2023Clinical Cancer Research14 citations Open access
Semantic Scholar
Impaired Neurocognitive Functioning 3 Months Following Diagnosis of High-Risk Acute Lymphoblastic Leukemia: A Report from the Children’s Oncology Group (COG)
K. Hardy, J. Kairalla, Anthony R. Gioia, Hannah Weisman +8 more
2023Pediatric Blood & Cancer13 citations Open access
Semantic Scholar
Persistence of chemotherapy-induced peripheral neuropathy despite vincristine reduction in childhood b-acute lymphoblastic leukemia.
R. Rodwin, J. Kairalla, Emily Hibbitts, M. Devidas +11 more
2022Journal of the National Cancer Institute6 citations Open access
Semantic Scholar
A Pilot Study of Azacitidine As Epigenetic Priming for Chemotherapy in Infants Less Than 1 Year of Age with KMT2A-Rearranged Acute Lymphoblastic Leukemia (ALL); Results from the Children's Oncology Group (COG) Trial AALL15P1
Erin M. Guest, J. Kairalla, M. Devidas, Emily Hibbitts +14 more
2022Blood5 citations
Semantic Scholar
The assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemia
R. Rodwin, N. DelRocco, Emily Hibbitts, M. Devidas +13 more
2023Pediatric Blood & Cancer3 citations Open access
Semantic Scholar
Phase II trial of irinotecan/temozolomide/dinutuximab/granulocyte macrophage colony stimulating factor (I/T/DIN/GMCSF) in children with relapsed/refractory neuroblastoma (NBL): A report from the Children's Oncology Group (COG).
R. Mody, A. Naranjo, A. Yu, Emily Hibbitts +11 more
20183 citations
Semantic Scholar
Risk stratification including FOXO1 fusion status (FOXO1) in patients with rhabdomyosarcoma (RMS) treated on six recent frontline trials: A report from the Children's Oncology Group (COG).
Emily Hibbitts, D. Hawkins, C. Arndt, Yueh-Yun Chi
20173 citations
Semantic Scholar
Diminished Quality of Life Despite Reduced Treatment in Children with B-Lymphoblastic Leukemia: Children’s Oncology Group AALL0932
Lyn M. Balsamo, J. Kairalla, Emily Hibbitts, R. Rodwin +11 more
2026Pediatric Blood & Cancer2 citations Open access
Semantic Scholar
Adverse Family Outcomes in Children With B-Cell Acute Lymphoblastic Leukemia From the Multicenter Trial Children's Oncology Group AALL0932.
R. Rodwin, J. Kairalla, Emily Hibbitts, Lyn M. Balsamo +14 more
2026The Journal of the National Comprehensive Cancer Network1 citations
Semantic Scholar
Additional Induction Intrathecal Cytarabine for Patients with CNS2 Disease at Diagnosis Is Not Beneficial for Patients with B-ALL Treated on Children's Oncology Group Protocols AALL0932 and AALL1131
Cathy A Lee-Miller, J. Kairalla, Emily Hibbitts, N. Winick +11 more
2024Blood1 citations
Semantic Scholar
The Impact of Cumulative Anesthesia Exposure on Neurocognitive Outcomes in Children with High-Risk Precursor B Acute Lymphoblastic Leukemia: A Multicenter Children's Oncology Group Study
S. Alexander, S. Gupta, J. Kairalla, Emily Hibbitts +11 more
2022Blood1 citations Open access
Semantic Scholar
GD2 as a circulating tumor biomarker (CTB) for neuroblastoma (NBL).
F. Balis, Christine M. Busch, A. Desai, Emily Hibbitts +4 more
20181 citations
Semantic Scholar
Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes
Cathy A Lee-Miller, J. Kairalla, Emily Hibbitts, N. Winick +12 more
2026Blood Advances0 citations Open access
Semantic Scholar
Caregivers’ Perspectives on Changes in Family Life During B-ALL Therapy: A Qualitative Study From the Children’s Oncology Group
Alexandra Dreyzin, Megan E. Ware, K. Stumbras, J. Kairalla +14 more
2025Pediatric Blood & Cancer0 citations
Semantic Scholar
Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1
Kelly E. Faulk, J. Kairalla, Emily Hibbitts, J. Long-Boyle +11 more
2025Blood Advances0 citations Open access
Semantic Scholar
Outcomes in children with NCI standard-risk b-acute lymphoblastic leukemia treated with intensified post-induction therapy: Results from Children's Oncology Group studies AALL0932 and AALL1131
Ruth W. Wang'ondu, A. Angiolillo, M. Devidas, Karen R. Rabin +16 more
2025Blood0 citations
Semantic Scholar
Utility of a Second Interim Maintenance Phase to Improve Outcomes for Pediatric Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group
E. Orgel, M. Burke, J. Kairalla, Emily Hibbitts +16 more
2024Blood0 citations
Semantic Scholar
Reply to C Matava et al
S. Alexander, J. Kairalla, S. Gupta, Emily Hibbitts +13 more
2024Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Physical and emotional quality of life in children with B-acute lymphoblastic leukemia randomized to every 4- vs. 12-week vincristine/dexamethasone during maintenance: Children’s Oncology Group AALL0932.
Lyn M. Balsamo, J. Kairalla, Emily Hibbitts, R. Rodwin +11 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
Segmental chromosome aberrations and clinical response impact outcome of inss stage III patients ≥18 months with unfavorable histology and without MYCN amplification: A Children’s Oncology Group (COG) report.
N. Pinto, A. Naranjo, Emily Hibbitts, Xiangming Ding +8 more
20200 citations
Semantic Scholar
Predictors of differential response to induction chemotherapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG).
N. Pinto, Emily Hibbitts, S. Kreissman, M. Granger +7 more
20180 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Kairalla×17
Invite
J. Kairalla — researcher profile on SciRah
M. Devidas×13
Invite
M. Devidas — researcher profile on SciRah
E. Raetz×11
Invite
E. Raetz — researcher profile on SciRah
M. Loh×11
Invite
M. Loh — researcher profile on SciRah

Stephen P. Hunger

×10

Invite

Stephen P. Hunger — researcher profile on SciRah

Invite

N. Winick — researcher profile on SciRah

Invite

R. Schore — researcher profile on SciRah

Invite

A. Naranjo — researcher profile on SciRah

Invite

W. Salzer — researcher profile on SciRah

Invite

R. Bagatell — researcher profile on SciRah

Invite

M. Burke — researcher profile on SciRah

Invite

S. Hunger — researcher profile on SciRah